Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges
Adamantia Nikolaidi(Mitera Hospital), Christos Papadimitriou(National and Kapodistrian University of Athens), Elena Fountzilas(European University Cyprus), Helen Gogas(National and Kapodistrian University of Athens), Florentia Fostira(National Centre of Scientific Research "Demokritos"), Amanda Psyrri(National and Kapodistrian University of Athens)
Cited by 35
Related Papers
Review of precision cancer medicine: Evolution of the treatment paradigm
|Cancer Treatment Reviews|2020|747
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
|Journal of Clinical Oncology|2010|488
Clinical trial design in the era of precision medicine
|Genome Medicine|2022|279
Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
|Cancer Research|2011|266